CN104458375B - 核酸适体及其衍生物的用途及对组织冰冻切片的快速成像方法 - Google Patents
核酸适体及其衍生物的用途及对组织冰冻切片的快速成像方法 Download PDFInfo
- Publication number
- CN104458375B CN104458375B CN201410739761.9A CN201410739761A CN104458375B CN 104458375 B CN104458375 B CN 104458375B CN 201410739761 A CN201410739761 A CN 201410739761A CN 104458375 B CN104458375 B CN 104458375B
- Authority
- CN
- China
- Prior art keywords
- tissue
- section
- aptamer
- epcam
- freezing section
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108091023037 Aptamer Proteins 0.000 title claims abstract description 84
- 238000007710 freezing Methods 0.000 title claims abstract description 51
- 230000008014 freezing Effects 0.000 title claims abstract description 51
- 238000003384 imaging method Methods 0.000 title claims abstract description 36
- 201000010099 disease Diseases 0.000 claims abstract description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 15
- 102000018651 Epithelial Cell Adhesion Molecule Human genes 0.000 claims description 68
- 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 claims description 68
- 239000002245 particle Substances 0.000 claims description 9
- 238000004416 surface enhanced Raman spectroscopy Methods 0.000 claims description 9
- SNBCLPGEMZEWLU-QXFUBDJGSA-N 2-chloro-n-[[(2r,3s,5r)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl]acetamide Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CNC(=O)CCl)[C@@H](O)C1 SNBCLPGEMZEWLU-QXFUBDJGSA-N 0.000 claims 1
- 238000002405 diagnostic procedure Methods 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 15
- 238000003745 diagnosis Methods 0.000 abstract description 11
- 230000003902 lesion Effects 0.000 abstract description 7
- 108091008104 nucleic acid aptamers Proteins 0.000 abstract description 7
- 230000009871 nonspecific binding Effects 0.000 abstract description 6
- 239000000090 biomarker Substances 0.000 abstract description 5
- 210000001519 tissue Anatomy 0.000 description 105
- 239000012188 paraffin wax Substances 0.000 description 33
- 206010028980 Neoplasm Diseases 0.000 description 20
- 238000004043 dyeing Methods 0.000 description 16
- 238000001069 Raman spectroscopy Methods 0.000 description 15
- 201000011510 cancer Diseases 0.000 description 15
- 206010009944 Colon cancer Diseases 0.000 description 13
- 238000012744 immunostaining Methods 0.000 description 13
- 208000029742 colonic neoplasm Diseases 0.000 description 10
- 238000011534 incubation Methods 0.000 description 10
- 230000014509 gene expression Effects 0.000 description 8
- 230000003834 intracellular effect Effects 0.000 description 8
- 239000003550 marker Substances 0.000 description 7
- 210000001789 adipocyte Anatomy 0.000 description 6
- 210000000577 adipose tissue Anatomy 0.000 description 6
- 239000000427 antigen Substances 0.000 description 6
- 108091007433 antigens Proteins 0.000 description 6
- 102000036639 antigens Human genes 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 239000000975 dye Substances 0.000 description 6
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 210000001072 colon Anatomy 0.000 description 5
- 238000000799 fluorescence microscopy Methods 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 230000008520 organization Effects 0.000 description 5
- 201000001275 rectum cancer Diseases 0.000 description 5
- 238000004153 renaturation Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000010166 immunofluorescence Methods 0.000 description 4
- 210000000664 rectum Anatomy 0.000 description 4
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 3
- 208000008589 Obesity Diseases 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 235000020824 obesity Nutrition 0.000 description 3
- 238000004393 prognosis Methods 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 210000002027 skeletal muscle Anatomy 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 210000000593 adipose tissue white Anatomy 0.000 description 2
- 229960000419 catumaxomab Drugs 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 201000010989 colorectal carcinoma Diseases 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000009509 drug development Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 201000010063 epididymitis Diseases 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000011664 signaling Effects 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000002626 targeted therapy Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000005443 Circulating Neoplastic Cells Diseases 0.000 description 1
- 208000030808 Clear cell renal carcinoma Diseases 0.000 description 1
- 108091008102 DNA aptamers Proteins 0.000 description 1
- 101150084967 EPCAM gene Proteins 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 206010025538 Malignant ascites Diseases 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108091008103 RNA aptamers Proteins 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000002771 cell marker Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 206010073251 clear cell renal cell carcinoma Diseases 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 230000004736 colon carcinogenesis Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 1
- 230000002055 immunohistochemical effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 206010027191 meningioma Diseases 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000010827 pathological analysis Methods 0.000 description 1
- 208000014081 polyp of colon Diseases 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108700022737 rat Fat1 Proteins 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 206010038038 rectal cancer Diseases 0.000 description 1
- 208000020615 rectal carcinoma Diseases 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229940126586 small molecule drug Drugs 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410739761.9A CN104458375B (zh) | 2014-12-08 | 2014-12-08 | 核酸适体及其衍生物的用途及对组织冰冻切片的快速成像方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410739761.9A CN104458375B (zh) | 2014-12-08 | 2014-12-08 | 核酸适体及其衍生物的用途及对组织冰冻切片的快速成像方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104458375A CN104458375A (zh) | 2015-03-25 |
CN104458375B true CN104458375B (zh) | 2018-05-29 |
Family
ID=52904789
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410739761.9A Active CN104458375B (zh) | 2014-12-08 | 2014-12-08 | 核酸适体及其衍生物的用途及对组织冰冻切片的快速成像方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104458375B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112985953A (zh) * | 2021-02-22 | 2021-06-18 | 武汉大学 | 一种利用放大镜及染料的手术标本标记方法 |
CN114317542A (zh) * | 2021-09-30 | 2022-04-12 | 中国药科大学 | 一种诱导肿瘤细胞上皮间质转化药物的筛选探针及其制备方法和应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103387990B (zh) * | 2012-09-24 | 2016-01-06 | 厦门大学 | 上皮细胞粘附分子的核酸适体EpCAM B及其制备方法 |
-
2014
- 2014-12-08 CN CN201410739761.9A patent/CN104458375B/zh active Active
Non-Patent Citations (4)
Title |
---|
Gold Nanoparticle Based Surface-Enhanced Raman Scattering Spectroscopy of Cancerous and Normal Nasopharyngeal Tissues Under Near-Infrared Laser Excitation;SHANGYUAN FENG et al.;《APPLIED SPECTROSCOPY》;20091231;摘要,第1090页"EXPERIMENTAL",第1091-1094页"RESULTS AND DISCUSSION" * |
Selection of DNA Aptamers against Epithelial Cell Adhesion Molecule for Cancer Cell Imaging and Circulating Tumor Cell Capture;Yanling Song et al.;《Analytical Chemistry》;20130312;第85卷;第4141-4149页 * |
基于表面增强拉曼光谱的结肠癌组织免疫分析;席刚琴 等;《中国激光》;20110930;第38卷(第9期);摘要 * |
脂肪细胞特异性核酸适配体的筛选、分子识别及应用初探;刘俊;《中国博士学位论文全文数据库 医药卫生科技辑》;20121215;第49-64页"第三部分脂肪细胞核酸适配体的特异性分子识别及应用初探" * |
Also Published As
Publication number | Publication date |
---|---|
CN104458375A (zh) | 2015-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gross-Thebing et al. | Simultaneous high-resolution detection of multiple transcripts combined with localization of proteins in whole-mount embryos | |
CN107893101A (zh) | 一种用于肿瘤疾病早期诊断的试剂盒、方法及应用 | |
Lotan et al. | Prospective evaluation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder | |
CN106980018B (zh) | 一种应用cd45免疫荧光联合cep17探针鉴定循环肿瘤细胞的试剂盒及其应用 | |
CN104593372A (zh) | 一种检测胰腺导管癌的核酸适配体、试剂盒及方法 | |
CN104450893B (zh) | 一种用于检测膀胱癌的探针组及基因芯片 | |
CN101726602A (zh) | 一种检测Legumain蛋白判断卵巢癌预后的方法 | |
CN104458375B (zh) | 核酸适体及其衍生物的用途及对组织冰冻切片的快速成像方法 | |
CN109161593A (zh) | 环状RNA和microRNA在结直肠癌筛查诊断的应用 | |
KR20140034124A (ko) | 암종의 진단방법 및 그의 용도 | |
CN105624166B (zh) | 一种检测人膀胱移行细胞癌细胞的核酸适配体及其在制备检测制剂中的应用 | |
CN112760323A (zh) | 一种直肠癌核酸适体的组织样本快速筛选及其在制备检测制剂中的应用 | |
CN105483246B (zh) | 基因的差异表达在口腔癌诊断中的应用 | |
Wong et al. | Nuclear β-catenin and Ki-67 expression in choriocarcinoma and its pre-malignant form | |
CN106480188B (zh) | 转移性前列腺癌早期预测的分子探针、试剂盒及该分子探针的应用 | |
Georges et al. | Provision of rapid and specific ex vivo diagnosis of central nervous system lymphoma from rodent xenograft biopsies by a fluorescent aptamer | |
CN115094063A (zh) | 一种肺癌早期智能诊断的多价可激活适配体探针及其制备与应用 | |
CN108169488B (zh) | 一种基于核酸适配体肺转移性骨肉瘤组织免疫荧光试剂盒 | |
Liu et al. | Evaluation of acridine orange florescence in exfoliative urinary cytology for diagnosing bladder carcinoma | |
Ingle et al. | Fine Needle Aspiration Cytology [FNAC] | |
WO2013099865A1 (ja) | Acf検出方法 | |
Zhang et al. | Immunocytochemistry Based on a Cell-Type-Specific Aptamer for Rapid Immunostaining of Adenocarcinoma Cells in Clinical Serosal Fluids | |
TWI833069B (zh) | 核酸探針組、核酸側流檢測套組以及該核酸側流檢測套組之用途 | |
US11884638B2 (en) | Compound or salt thereof, composition for cysteine detection, fluorescent probe and composition for diagnosing cancer containing the same, method for detecting cysteine, method for providing information for diagnosing cancer, and method for producing compound | |
CN109554369A (zh) | 核酸适配体在识别并结合碱性磷酸酶异源二聚体中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Liu Huixia Inventor after: Pu Ying Inventor after: Zhang Jiani Inventor after: Tan Weihong Inventor after: Lu Yi Inventor after: Liu Zhenxu Inventor after: Yuan Peng Inventor after: Liu Jun Inventor before: Liu Huixia Inventor before: Pu Ying Inventor before: Tan Weihong Inventor before: Lu Yi Inventor before: Liu Zhenxu Inventor before: Yuan Peng Inventor before: Liu Jun |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20180419 Address after: 410008 Hunan province Changsha Kaifu District, Xiangya Road No. 87 Applicant after: XIANGYA HOSPITAL OF CENTRAL SOUTH University Address before: XIANGYA HOSPITAL OF CENTRAL SOUTH University Applicant before: Liu Huixia |
|
GR01 | Patent grant | ||
GR01 | Patent grant |